🇺🇸 FDA
Patent

US 10800813

Modulation of structured polypeptide specificity

granted A61KA61K38/10A61K38/12

Quick answer

US patent 10800813 (Modulation of structured polypeptide specificity) held by BicycleRD Limited expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BicycleRD Limited
Grant date
Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
48
CPC classes
A61K, A61K38/10, A61K38/12, A61P, A61P1/04